You have 9 free searches left this month | for more free features.

Kidney cancer

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

Available
  • Clear Cell Kidney Cancer
  • +2 more
  • Axitinib 5 MG
  • (no location specified)
Jul 3, 2023

Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing

Recruiting
  • Carcinoma
  • +4 more
    • Nanjing, Jiangsu, China
      Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
    Jun 30, 2023

    Renal Cancer Trial in Milan (Radical or partial nephrectomy)

    Recruiting
    • Renal Cancer
    • Radical or partial nephrectomy
    • Milan, MI, Italy
      IRCCS Ospedale San Raffaele
    Nov 23, 2023

    Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)

    Not yet recruiting
    • Prostate Cancer
    • +11 more
    • Guided physical exercise
    • +2 more
    • Tampere, Länsi-Suomi, Finland
      Tampere University Hospital
    Apr 3, 2023

    Birt Hogg-Dube Syndrome and Characterization of Predisposition

    Recruiting
    • Kidney Neoplasms
    • +3 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Dec 22, 2022

      Kidney Cancer Trial in Tampa, Atlanta, Nashville (Blood Sparing Protocol, Standard Blood Replacement)

      Suspended
      • Kidney Cancer
      • Blood Sparing Protocol
      • Standard Blood Replacement
      • Tampa, Florida
      • +2 more
      Aug 26, 2022

      Nivolumab in Recurring Kidney Cancer Participants

      Completed
      • Kidney Cancer
      • Renal Cancer
      • Non-Interventional
      • Tokyo, Japan
        Local Institution - 0001
      Oct 19, 2022

      Renal Cancer, Tumor, Solid, Kidney Cancer Trial (HistoSonics Edison System)

      Not yet recruiting
      • Renal Cancer
      • +4 more
      • HistoSonics Edison System
      • (no location specified)
      Apr 18, 2023

      Prostate Cancer, Kidney Cancer Trial in Chambersburg (High intensity approach, Low intensity approach)

      Not yet recruiting
      • Prostate Cancer
      • Kidney Cancer
      • High intensity approach
      • Low intensity approach
      • Chambersburg, Pennsylvania
        Wellspan
      Nov 21, 2023

      Kidney Tumor Trial in France (blood sampling for ITK dosage)

      Recruiting
      • Kidney Neoplasm
      • blood sampling for ITK dosage
      • Marseille, France
      • +4 more
      Jan 6, 2023

      UroCCR Database: French Research Network for Kidney Cancer

      Recruiting
      • Kidney Cancer
      • Radical nephrectomy versus partial nephrectomy (according surgeon judgement)
      • Angers, France
      • +21 more
      Nov 7, 2022

      Kidney Cancer Trial in New York (Iodine-131 radiolabeled chimeric mAb G250 (131I-cG250))

      Completed
      • Kidney Cancer
      • Iodine-131 radiolabeled chimeric monoclonal antibody G250 (131I-cG250)
      • New York, New York
        Memorial Sloan-Kettering Cancer Center
      Oct 3, 2022

      Survivorship, Prostate Cancer, Kidney Cancer Trial in Cork (Physiotherapy, Dietitian Support, Nursing and Psychosocial)

      Recruiting
      • Survivorship
      • +5 more
      • Physiotherapy
      • +2 more
      • Cork, Ireland
        Cork University Hospital
      Jul 17, 2023

      KIdney aNd blooD prESsure ouTcomes in Childhood Cancer Survivors

      Not yet recruiting
      • Childhood Cancer
      • +4 more
        • (no location specified)
        Nov 28, 2023

        MRI Guided Radiotherapy and Radiobiological Data: ISRAR Database

        Not yet recruiting
        • Prostate Cancer
        • +4 more
        • 3 MRI sequences (T2*, IVIM and Multi Echo-Gradient), without injection, are performed
        • (no location specified)
        Sep 18, 2023

        Kidney Cancer Trial in Tampa (Pembrolizumab, Interleukin-2)

        Active, not recruiting
        • Kidney Cancer
        • Tampa, Florida
          H. Lee Moffitt Cancer Center and Research Institute
        Jun 21, 2022

        Breast Cancer, Hodgkin Lymphoma, Kidney Cancer Trial (Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH)

        Not yet recruiting
        • Breast Cancer
        • +9 more
        • Assessment tool IA3-CP with SDoH
        • Assessment tool IA3-CP without SDoH
        • (no location specified)
        May 22, 2023

        Hereditary Leiomyomatosis Renal Cell Cancer - Study of Genetic

        Recruiting
        • Renal Tumor Histology
        • +2 more
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Dec 28, 2022

          Oligometastatic Renal Cell Carcinoma Trial in Rome (Pembrolizumab injection plus metastasis directed treatment (surgery or RT),

          Not yet recruiting
          • Oligometastatic Renal Cell Carcinoma
          • Pembrolizumab injection plus metastasis directed treatment (surgery or RT)
          • Tumor resection or RT
          • Rome, RM, Italy
            Fondazione Policlinico Universitario "A. Gemelli" IRCCS
          Oct 10, 2022

          Describe Kidney Cancer Patient Population Treatment, and Results

          Not yet recruiting
          • Renal Cell Cancer
          • +6 more
            • (no location specified)
            May 2, 2022

            Urologic Cancer, Urologic Tumors, Bladder Cancer Trial in Boston (Electromagnetic Guided Laparoscopy, Ultrasound)

            Not yet recruiting
            • Urologic Cancer
            • +7 more
            • Electromagnetic Guided Laparoscopy
            • Ultrasound
            • Boston, Massachusetts
              Brigham and Women's Hospital
            Jun 8, 2023

            Frequency, Clinical Phenotype and Genetic Analysis of Heritable

            Not yet recruiting
            • Renal Tumor Histology
            • +13 more
            • Gene test
            • Shanghai, Shanghai, China
              Ethics Committee of Shanghai Renji Hospital
            Sep 6, 2022

            oncRNA Stratification of Cancer by Size and Stage

            Not yet recruiting
            • Kidney Cancer
            • +32 more
            • Exai oncRNA blood test
            • (no location specified)
            Apr 27, 2023

            Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

            Recruiting
            • Kidney Cancer
            • +11 more
            • 13C-Glucose
            • +4 more
            • Dallas, Texas
              University of Texas Southwestern Medical Center
            Dec 1, 2022

            Cancer of Kidney, Kidney Cancer, Renal Cancer Trial in New York (124-Iodine-cG250 (124I-cG250))

            Completed
            • Cancer of Kidney
            • +6 more
            • 124-Iodine-cG250 (124I-cG250)
            • New York, New York
              Memorial Sloan-Kettering Cancer Center
            Oct 3, 2022